Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMBR | Common Stock, par value $0.001 per share | Award | $0 | +4.1K | +205% | $0.00 | 6.1K | Apr 15, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMBR | Stock Option (right to buy) | Award | $0 | +4.1K | $0.00 | 4.1K | Apr 15, 2023 | Common Stock | 4.1K | $1.66 | Direct | F2 |
Id | Content |
---|---|
F1 | On April 15, 2023, the Reporting Person was granted 4,100 restricted stock units, which will be settled in shares of common stock, par value $0.001. The restricted stock units vest in 12 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date. |
F2 | 25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date. |